Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
McKinsey
Moodys
Merck
Harvard Business School

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for AMITIZA

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for AMITIZA (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $8,224,613
INSIDE ANOTHER STORE $90,688,028
[disabled in preview] $383,556,391
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 24,059
INSIDE ANOTHER STORE 242,402
[disabled in preview] 805,997
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $117,668,747
MEDICARE $151,831,525
[disabled in preview] $212,968,760
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for AMITIZA
Drug Units Sold Trends for AMITIZA

Annual Sales Revenues and Units Sold for AMITIZA

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
AMITIZA   Start Trial   Start Trial 2017
AMITIZA   Start Trial   Start Trial 2016
AMITIZA   Start Trial   Start Trial 2015
AMITIZA   Start Trial   Start Trial 2014
AMITIZA   Start Trial   Start Trial 2013
AMITIZA   Start Trial   Start Trial 2012
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Dow
Johnson and Johnson
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.